Multicenter Phase II Clinical Study of Iodine-131-Rituximab Radioimmunotherapy in Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma

M.F. Leahy, J.F. Seymour, R.J. Hicks, J Turner

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	4418-4425
Journal	Journal of Clinical Oncology
Volume	24
Issue number	27
DOIs	https://doi.org/10.1200/JCO.2005.05.3470
Publication status	Published - 2006

Access to Document

@article{2747be3d0a404bf7ad170c650895964f,

title = "Multicenter Phase II Clinical Study of Iodine-131-Rituximab Radioimmunotherapy in Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma",

author = "M.F. Leahy and J.F. Seymour and R.J. Hicks and J Turner",

year = "2006",

doi = "10.1200/JCO.2005.05.3470",

language = "English",

volume = "24",

pages = "4418--4425",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "27",

}

TY - JOUR

T1 - Multicenter Phase II Clinical Study of Iodine-131-Rituximab Radioimmunotherapy in Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma

AU - Leahy, M.F.

AU - Seymour, J.F.

AU - Hicks, R.J.

AU - Turner, J

PY - 2006

Y1 - 2006

U2 - 10.1200/JCO.2005.05.3470

DO - 10.1200/JCO.2005.05.3470

M3 - Article

C2 - 16940276

SN - 0732-183X

VL - 24

SP - 4418

EP - 4425

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 27

ER -